The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...
In the 6MM, the total diagnosed prevalent cases of H. pylori infection were around 147 million in 2025 and are projected to grow during the forecast period (2026-2036).
一些您可能无法访问的结果已被隐去。
显示无法访问的结果